Doha – September 22, 2026 -- OxiWear Inc. has signed an exclusive distribution partnership with Alfardan Medical with Northwestern Medicine (AMNM) to bring its wearable physiological measurement technology into Qatar, marking the U.S. company's latest push into the Middle East.
OxiWear taps AMNM's local network to enter Qatar's healthcare technology market
Under the agreement, OxiWear and AMNM will jointly handle distribution, market development, and customer engagement for OxiWear's continuous physiological measurement products across Qatar. AMNM, a multi-specialty day-care surgery center based in Lusail and operated in affiliation with Chicago-based Northwestern Medicine, provides OxiWear with an established clinical network and regional expertise in outpatient care.
Deal extends OxiWear's international footprint beyond the United States
Arlington, Virginia-headquartered OxiWear develops wearable technology and a connected platform for continuous physiological data capture across research, performance, and industrial applications. The Qatar agreement adds to the company's existing operations in the United States and international markets, as it seeks new distribution channels in the Gulf region.
Executives cite Qatar's innovation ecosystem as a driver for the tie-up
"Qatar has built an incredible ecosystem around technology and innovation, and we are excited to partner with AMNM as we continue expanding OxiWear internationally," said Shavini Fernando, Founder and CEO of OxiWear. Dr. Abdulla Al-Ansari, CEO of AMNM, said the partnership supports the introduction of new medical technologies into Qatar's healthcare ecosystem.